(Q21245540)

English

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis

scientific article

In more languages

Statements

scholarly article

0 references

8 references

13 March 2019

14 March 2019

25 June 2019

19 September 2019

9 October 2019

12 October 2019

17 November 2019

20 November 2019

1 reference

based on heuristic

inferred from title

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis (English)

0 references

9 references

13 March 2019

14 March 2019

25 June 2019

19 September 2019

9 October 2019

12 October 2019

17 November 2019

20 November 2019

29 May 2020

biomedical investigative technique

1 reference

19 September 2019

genitourinary system

1 reference

9 October 2019

1 reference

12 October 2019

1 reference

17 November 2019

1 reference

20 November 2019

1 reference

based on heuristic

inferred from title

author name string

Philippe Lehert

1

author given names

Philippe

author last names

Lehert

1 reference

Dimensions Publication ID

18 August 2022

Joan C Schertz

2

author given names

Joan C

author last names

Schertz

1 reference

Dimensions Publication ID

18 August 2022

Diego Ezcurra

3

author given names

Diego

author last names

Ezcurra

1 reference

Dimensions Publication ID

18 August 2022

language of work or name

0 references

publication date

16 September 2010

9 references

13 March 2019

14 March 2019

25 June 2019

19 September 2019

9 October 2019

12 October 2019

17 November 2019

20 November 2019

29 May 2020

Reproductive Biology and Endocrinology

8 references

13 March 2019

14 March 2019

25 June 2019

19 September 2019

9 October 2019

12 October 2019

17 November 2019

20 November 2019

8

0 references

1

0 references

112

0 references

copyright license

Creative Commons Attribution 2.0 Generic

8 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

14 March 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

19 September 2019

Europe PubMed Central

9 October 2019

Europe PubMed Central

12 October 2019

Europe PubMed Central

17 November 2019

Europe PubMed Central

20 November 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

19 March 2017

A comparison of statistical methods for meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

19 March 2017

Biological versus chronological ovarian age: implications for assisted reproductive technology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Identifying real differences in live birth rates between HMG and rFSH in IVF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Highly purified hMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Morphological selection of gametes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Communicating the benefits and harms of treatments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

Recombinant gonadotropins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

A method for assessing the quality of a randomized control trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

12 September 2017

To add or not to add LH: comments on a recent commentary.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

27 September 2017

Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

30 May 2018

Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

30 May 2018

Variation in baseline risk as an explanation of heterogeneity in meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

30 May 2018

Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An ana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2954883

29 November 2018

Analytical identification of additional impurities in urinary-derived gonadotrophins

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of recombinant follicle stimulating hormone in a woman with allergic reaction to menotropin: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of recombinant versus urinary-derived FSH: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficiency and efficacy of exogenous gonadotrophins containing LH activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. II. Comparison of hMG and recombinant FSH

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20846363

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1477-7827-8-112

0 references

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1477-7827-8-112

release_225dckgkqzhgxajmmeaqilbyim

1 reference

https://api.fatcat.wiki/v0/release/225dckgkqzhgxajmmeaqilbyim

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21245540&oldid=2176703224"